Biojo Sciences Unites Industry Leaders to Bridge the Biotech “Valley of Death”
Seoul, South Korea — October 28, 2025
At a high-profile biotech forum hosted by Korea’s National Assembly, Biojo Sciences took center stage as a primary sponsor and thought leader, driving discussion on accelerating innovation and commercialization in the biotechnology industry. The event gathered leading scientists, investors, and policymakers.
(조승연 대표) CEO Jenny (Seungyun) Jo underscored that the biotech industry is still hampered by clinical entry obstacles and funding gaps. She outlined the company’s Two-Path Strategy, developing domestic pipelines while expanding overseas licensing and partnerships.
With its sponsorship, Biojo Sciences reaffirmed its commitment to connecting Korean innovation with global biotech ecosystems, including strategic partnerships in the U.S. and Europe.
